On behalf of the Executive Committee and the Science Committee, we would like to invite you to participate in the 24^th EFORT Congress in Vienna, Austria from 24 to 26 May 2023. The annual meeting of EFORT is the largest platform for European Orthopaedics to exchange knowledge and experience within Europe but also with colleagues from other parts of the world.

Congress newsletter

This year our main theme is “Building the Future of Orthopaedics and Traumatology“. By deliberately choosing this broad statement, we wanted on the one hand to be able to cover the breadth of the O&T specialty and on the other, to inspire some stability, if possible, especially in these uncertain times as we strive to find new visions.

The EFORT 2023 Advanced Scientific Programme is available online with more than 160 sessions and 1.500 presenters were assigned to actively participate and share their expertise over the 3 days of the congress in Lisbon. Consult all the details in the EFORT Congress website!

Register online registration to the  24^th EFORT Congress!
Login or create your account on the EFORT online official registration platform.
This is a 100% face-to-face event. Join us from 24 to 26 May 2023 in Vienna, Austria!

More information

• EFORT Annual Congress Vienna 2023 Website
• Video Welcome Message from EFORT President Prof. E. Gómez Barrena
• Advanced Scientific Programme
• EFORT online official registration platform | Congress Fees
• The EFORT Marketplace

On behalf of the Executive Committee and the Science Committee, we would like to invite you to participate in the 24^th EFORT Congress in Vienna, Austria from 24 to 26 May 2023. The annual meeting of EFORT is the largest platform for European Orthopaedics to exchange knowledge and experience within Europe but also with colleagues from other parts of the world.

Congress newsletter

This year our main theme is “Building the Future of Orthopaedics and Traumatology“. By deliberately choosing this broad statement, we wanted on the one hand to be able to cover the breadth of the O&T specialty and on the other, to inspire some stability, if possible, especially in these uncertain times as we strive to find new visions.

The EFORT 2023 Advanced Scientific Programme is available online with more than 160 sessions and 1.500 presenters were assigned to actively participate and share their expertise over the 3 days of the congress in Lisbon. Consult all the details in the EFORT Congress website!

Register online registration to the  24^th EFORT Congress!
Login or create your account on the EFORT online official registration platform.
This is a 100% face-to-face event. Join us from 24 to 26 May 2023 in Vienna, Austria!

More information

• EFORT Annual Congress Vienna 2023 Website
• Video Welcome Message from EFORT President Prof. E. Gómez Barrena
• Advanced Scientific Programme
• EFORT online official registration platform | Congress Fees
• The EFORT Marketplace

Dear EFORT Member, dear EFORT Partner,

We are pleased to inform you about our next EFORT / ESTES Webinar entitled "Fractures around the Elbow: Floating Elbow Injuries" to take place on Monday 24 April 2023 from 19:00 to 20:00 (CET).

Free of charge registration is now open. May we kindly ask you to promote this Webinar on your websites and social media and also among your membership and colleagues. 

Click here to see the programme and find more information is also available on https://www.efort.org/webinars/

ERS School Courses
http://www.ersnet.org/ers/default.aspx?id_fiche=75480
http://www.ersnet.org/ers/default.aspx?id_dossier=8896&id_langue=3

General Information and Registration
Programme

The conference will focus on the world wide epidemic of the Insulin Resistance Syndrome and its prevalence in special population groups, women, and children. The program will cover the various fields which are part of the Insulin Resistance Syndrome including cardiovascular disease, PCOS, sleep apnea, hypertension, dyslipidemia, glucose intolerance, and endothelial dysfunction and will look into the emerging field of insulin resistance in liver disease and the development of certain cancers.
For more information: http://www.insulinresistance.us/